Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Daltonics and Applied Biosystems License MALDI-TOF Mass Spectrometry Technology

NEW YORK, June 7 – Bruker Daltonics will exclusively license MALDI-TOF mass spectrometry technology from Indiana University, and grant Applied Biosystems a sublicense to the technology, the companies said Thursday. 

The patented technology covers space-velocity correlation focusing (SVCF), or delayed extraction (DE), a technique related to MALDI-TOF mass spectrometry. SVCF technology improves the accuracy and sensitivity mass spectrometry analysis, according to the companies.  

Bruker Daltonics is licensing the technology from Indiana University’s Advanced Research and Technology Institute, the technology-transfer arm of the university. Applied Biosystems will pay Bruker multi-year royalty payments for its sublicense to the technology. Bruker Daltonics and Applied Biosystems have cross-licensed each other’s technology related to SVCF.

“We believe that it is in the best interest of our customers in this field to jointly promote the MALDI-TOF market via a licensing program," said Frank Laukien, CEO of Bruker Daltonics, and Michael Hunkapiller, president of Applied Biosystems, in a statement.  
The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.